Popolazione Mix: NEONATO-BAMBINO

Filtra

Data

Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na‹ve patients with spinal muscular atrophy and following switch from other therapies

Cerebral Palsy: Early Markers of Clinical Phenotype and Functional Outcome

Torna in alto